✦ LIBER ✦

The effects of agomelatine on sexual function in depressed patients and healthy volunteers

✍ Scribed by Angel Montejo; Susana Majadas; Sakina J. Rizvi; Sidney H. Kennedy

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 499 KB
Volume: 26
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.1243

No coin nor oath required. For personal study only.

✦ Synopsis

Background

Selective serotonin reuptake inhibitor (SSRI) and serotonin and norepinephrine reuptake inhibitor antidepressants are associated with high rates of treatment‐emergent sexual dysfunction (TESD) due to stimulation of serotonin receptors.

Objective

The objective is to evaluate the effect of agomelatine on sexual function in depressed patients.

Methods

This paper reviews published and unpublished data on sexual function with agomelatine in depressed patients and healthy volunteers.

Results

Agomelatine, an agonist of melatonergic MT1 and MT2 receptors and antagonist of 5‐HT2 receptors, is associated with similar rates of sexual dysfunction compared with placebo and lower rates compared with other antidepressants. Twice as many sexually active depressed patients (n = 193) reported a deterioration of sexual function during 12 weeks of treatment with venlafaxine compared with agomelatine (15.2% vs. 8.2%, p < 0.0001); however, no differences were found with respect to arousal. Using the Arizona Sexual Experience Scale in depressed patients (n = 399), the incidence of treatment‐emergent sexual dysfunction (TESD) with agomelatine (3%) was significantly lower than placebo (8.6%) and selective serotonin reuptake inhibitors (10.1%). Among healthy male volunteers (n = 92), TESD was not increased compared with placebo in either agomelatine (25 and 50 mg/day) group over 8 weeks, and both were significantly lower than TESD with paroxetine (p < 0.0001). Moderate or severe TESD occurred in less than 5% of subjects receiving agomelatine versus 62% who received paroxetine (p < 0.001).

Conclusion

📜 SIMILAR VOLUMES

The effect of sleep deprivation on memor

The effect of sleep deprivation on memory and psychomotor function in healthy volunteers

✍ N. Quigley; J. F. Green; D. Morgan; C. Idzikowski; D. J. King 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

Benzodiazepines and other psychotropic drugs have been implicated in the production of memory deficits. The mechanism is unclear, but both a distinct pharmacological action and a non-specific sedative effect have been suggested as being causal or contributory. These two postulated mechanisms of acti

Impact of the novel antidepressant agome

Impact of the novel antidepressant agomelatine on disturbed sleep–wake cycles in depressed patients

✍ Maria-Antonia Quera-Salva; Patrick Lemoine; Christian Guilleminault 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract ## Background Disturbance of sleep–wake cycles is common in major depressive disorder (MDD), usually as insomnia, but also as hypersomnia or reduced daytime alertness. Agomelatine, an MT~1~ and MT~2~ receptor agonist and 5‐HT~2C~ receptor antagonist, represents a novel approach in MDD,

The effects of fluoxetine and dothiepin

The effects of fluoxetine and dothiepin on cognitive function in depressed patients in general practice

✍ D. B. Fairweather; N. Stanley; J. S. Yoon; I. Hindmarch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

The objective of this study was to assess whether there are any dierences between ¯uoxetine and dothiepin on cognitive function of patients with major depression (DSMIII-R). A randomized, double-blind, parallel group design, 6 week trial in patients in general practice was employed where patients we

THE EFFECT OF FOOD ON CABERGOLINE PHARMA

THE EFFECT OF FOOD ON CABERGOLINE PHARMACOKINETICS AND TOLERABILITY IN HEALTHY VOLUNTEERS

✍ S. Persiani; M. Rocchetti; M. A. Pacciarini; Beverly Holt; Steve Toon; Margherit 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 734 KB

STEVE TOON' AND MARGHERITA STROLIN-BENEDETTI. ## ABSTRA<JT The effect of food on the pharmacokinetics and tolerability of cabergoline in man was investigated. For this purpose an open, randomized, single-dose study was conducted in 12 healthy male volunteers who received 1 mg cabergoline as table

Effect of milk on the pharmacokinetics o

Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers

✍ Kaori Morimoto; Kozue Kishimura; Takaaki Nagami; Nao Kodama; Yoichiro Ogama; Mid 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

We previously showed that oseltamivir, a prodrug of the influenza virus neuraminidase inhibitor Ro 64-0802, is a substrate of proton-coupled oligopeptide transporter (PEPT1), and its intestinal absorption in rats is markedly inhibited by administration with milk. To investigate the importance of PEP

The effects of acute treatment with tand

The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers

✍ Masahiro Takahashi; Kunihiro Iwamoto; Yukiko Kawamura; Yukako Nakamura; Ryoko Is 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

## Abstract ## Objective To assess the effects of two anxiolytics, diazepam and tandospirone, on driving performance from methodological viewpoints taking frequent rear‐end collisions into account. ## Methods In this double‐blinded, three‐way crossover trial, 18 healthy males received acute dose